High-Dose Toremifene for Fulvestrant-Resistant Metastatic Breast Cancer: A Report of Two Cases

Publisher： Karger

E-ISSN： 1662-6575|7|2|383-388

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.7, Iss.2, 2014-06, pp. : 383-388

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Maximizing the Benefit-Cost Ratio of Anthracyclines in Metastatic Breast Cancer: Case Report of a Patient with a Complete Response to High-Dose Doxorubicin

By  

Case Reports in Oncology, Vol. 9, Iss. 3, 2016-12 ,pp. : 840-846

Karger

Access to resources Recommend Favorite

PSA Decrease with Fulvestrant Acetate in a Hormone-Resistant Metastatic Prostate Cancer Patient: A Case Report

By  

Case Reports in Oncology, Vol. 2, Iss. 1, 2009-04 ,pp. : 72-76

Karger

Access to resources Recommend Favorite

PSA Decrease with Fulvestrant Acetate in a Hormone-Resistant Metastatic Prostate Cancer Patient

By  

Oncology Research and Treatment, Vol. 33, Iss. 1-2, 2010-01 ,pp. : 57-59

Karger

Access to resources Recommend Favorite

High-Dose Chemotherapy in High-Risk Primary Breast Cancer

By  

Oncology Research and Treatment, Vol. 25, Iss. 2, 2002-05 ,pp. : 112-120

Karger

Access to resources Recommend Favorite

High-Dose Therapy for Breast Cancer – A Case of Suspended Animation

By  

Acta Haematologica, Vol. 114, Iss. 4, 2005-11 ,pp. : 248-254

Karger

Access to resources Recommend Favorite